Avinger Inc
AVGR
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.52M
Close$
$7.76
1536.9% upside
Current Fair Value
1536.9% upsideUndervalued by 1536.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.52 Million |
|---|---|
| Enterprise Value | $-2,958,636.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-23.31 |
| Beta | 1.1 |
| Outstanding Shares | 2,224,000 |
Return
| Return on Equity | -272.03% |
|---|---|
| Return on Assets | -77.50% |
| Return on Invested Capital | -427.04% |
Valuation & Multiples
| P/E Ratio | -0.02 |
|---|---|
| PEG | 0.02 |
| Price to Sales | 0.16 |
| Price to Book Ratio | 0.47 |
| Enterprise Value to Revenue | -0.41 |
| Enterprise Value to EBIT | 0.17 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.48 |
| Debt to Equity | 0.37 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
November 5, 2025
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Avinger Inc
CEO: Jeffrey Soinski Avinger is a commercial-stage medical device company that designs and develops the first and only image-guided, catheter-based system for the diagnosis and treatment of patients with Peripheral Artery Disease (PAD). PAD is estimated to a...